Michael Mitchell
Keine laufenden Positionen mehr
Profil
Michael Mitchell worked as the Head of Investor Relations at The Medicines Co. from 2002 to 2013.
He holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Providence College.
Ehemalige bekannte Positionen von Michael Mitchell
Unternehmen | Position | Ende |
---|---|---|
THE MEDICINES COMPANY | Investor Relations Kontakt | - |
Ausbildung von Michael Mitchell
Providence College | Undergraduate Degree |
Rutgers State University of New Jersey | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |